ONCY Oncolytics Biotech (ONCY) Insider Trading, Ownership & Congress Trades
Pharma & Biotech · Pharmaceutical preparations · CIK 0001129928
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
41
13F, latest reported quarter
Oncolytics Biotech insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for ONCOLYTICS BIOTECH INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Feb 12, 2026.
- +5.4% median (+5.4% mean) 90-day return after 2 previous buys.
- The trade is 4.4% of the 114,050 shares held after it.
- 9 other insiders bought within 30 days.
- 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Kelly Jared bought about $4.8K of ONCY on Mar 12, 2026; 9 other insiders bought within 30 days and 41 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 23.9% of the 41,849 shares held after it.
- 9 other insiders bought within 30 days.
- 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Parsons James T. bought about $10.3K of ONCY on Mar 11, 2026; 9 other insiders bought within 30 days and 41 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 4.2% of the 287,515 shares held after it.
- 9 other insiders bought within 30 days.
- 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Look Kirk bought about $10.1K of ONCY on Feb 12, 2026; 9 other insiders bought within 30 days and 41 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 6.1% of the 492,414 shares held after it.
- 9 other insiders bought within 30 days.
- 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Pisano Wayne bought about $25.2K of ONCY on Feb 12, 2026; 9 other insiders bought within 30 days and 41 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 4.3% of the 282,818 shares held after it.
- 9 other insiders bought within 30 days.
- 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Medical Officer Heineman Thomas Charles bought about $10.1K of ONCY on Feb 12, 2026; 9 other insiders bought within 30 days and 41 funds added in the latest 13F quarter.14 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
41 funds bought in last quarter
below 56% of Pharma & Biotech
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
7.2% of the float short (float per yahoo 2026-10-27) · 5.2 days to cover · settled 2026-10-15
more than 61% of Pharma & Biotech
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch ONCY
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-60.2%12M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ONCY: institutional holders (13F)
13F holdings, latest reported quarter
745,350 sh
$708.1K
260,903 sh
$247.8K
258,306 sh
$245.4K
$181.3K
185,712 sh
$176.4K
Congress trades in ONCY
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ONCY planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
ONCY mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Victory Extended Market Index Fund
$10.2K position · as of 2026-07-31
0.0%
Fidelity Nasdaq Composite Index Fund
$69.6K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Clinical pipeline
3 registered trials, 3 still running (ClinicalTrials.gov).
A status change is dated here weeks before the press release.
2
Phase 2
2 active
1
Multi-phase
1 active
Matched by sponsor name. Trials run under a subsidiary's
own name are not included.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 41 funds added last quarter. Each figure is a federal filing, dated the day it went public.
ONCY financials
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Operating income | -$28.7M | -$25.5M | n/a | n/a |
| Net income | -$28.8M | -$22.8M | -$27.8M | -$24.8M |
| EPS (diluted) | -0.30 | -0.30 | n/a | n/a |
| Operating cash flow | -$20.1M | -$19.9M | n/a | n/a |
| Cash | $5.2M | $11.1M | n/a | n/a |
SEC XBRL, fiscal years, as known on 2026-10-28
ONCY Stock Sonar score 2/7 axes
Find similar shapesCompare2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
